grayscale photo of person holding a new born baby
Photo by Michael Morse on

The US Food and Drug Administration on Friday approved for the first time a pill to treat postpartum depression, a condition believed to affect around half a million women in the country every year.

The antidepressant drug, called zuranolone, is "the first oral medication indicated to treat postpartum depression (PPD) in adults," the FDA said in a statement.

"Until now, treatment for PPD was only available as an IV injection given by a health care provider in certain health care facilities," it added.

"About one in eight women experience PPD symptoms after a recent live birth, and among those reporting symptoms, 75 per cent go untreated," said Dr Asima Ahmad, the chief medical officer at Carrot Fertility, a healthcare company in Menlo Park, California.

Register to read the full article.

Register for free for:

  • Access to ten free articles per month
  • Our weekly roundup of top stories
  • Monthly newsletters on topics of your choice

Subscribe for:

  • Unlimited article access each month
  • Crosswords and puzzles on Canadian holidays
  • Full newsletter access